Leaderboards/Pancreatic and Hepatic Oncology Research

Pancreatic and Hepatic Oncology Research

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Alessandro Mannucci
Vita-Salute San Raffaele University
2
Davide Placido
University of Copenhagen
3
Gregor Werba
NYU Langone Health
4
Lacey Padrón
Parker Institute for Cancer Immunotherapy
5
Urszula N. Wasko
Revolution Medicines (United States)
6
Gianluca Mucciolo
University of Cambridge
7
Kathleen M. McAndrews
The University of Texas MD Anderson Cancer Center
8
Sovanlal Mukherjee
Mayo Clinic Hospital
9
Miranda Gogishvili
Medical Technologies (Czechia)
10
Gauri Mirji
The Wistar Institute

Papers

1
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
Nature|2024
175 cit.
2
Publication in Abdominal Radiology (2024) [21 citations, W4390583128]
Abdominal Radiology|2024
21 cit.
3
Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future
CA A Cancer Journal for Clinicians|2025
15 cit.
4
Publication in Cancer Research (2024) [13 citations, W4402555591]
Cancer Research|2024
13 cit.
5
Publication in Scientific Reports (2025) [12 citations, W4410430919]
Scientific Reports|2025
12 cit.
6
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer
Science Translational Medicine|2025
9 cit.
7
Prediction of long-term recurrence-free and overall survival in early-onset colorectal cancer: the ENCORE multi-centre study
npj Precision Oncology|2025
5 cit.
8
An Exosome-Based Liquid Biopsy for the Detection of Early-Onset Colorectal Cancer: The ENCODER Multicenter Study
Gastroenterology|2025
4 cit.
9
Publication in Cell Reports (2025) [3 citations, W7117648023]
Cell Reports|2025
3 cit.
10
Publication in Gut (2026) [3 citations, W7158279150]
Gut|2026
3 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Ina Felau
National Cancer Institute
2
David Mallery
Translational Genomics Research Institute
3
Natália D. Aredes
Universidade Federal de Goiás
4
Michelle Bellair
Lunar and Planetary Institute
5
Moriah G. Nissan
Van Andel Institute
6
Costas A. Lyssiotis
University of Michigan
7
Ravid Straussman
Weizmann Institute of Science
8
Florencia McAllister
The University of Texas MD Anderson Cancer Center
9
Michal Barzily-Rokni
Shaare Zedek Medical Center
10
Wenming Wu
Chinese Academy of Medical Sciences & Peking Union Medical College

Papers

1
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Cell|2022
504 cit.
2
Uridine-derived ribose fuels glucose-restricted pancreatic cancer
Nature|2023
149 cit.
3
Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context
eLife|2022
120 cit.
4
OXPHOS promotes apoptotic resistance and cellular persistence in T <sub>H</sub> 17 cells in the periphery and tumor microenvironment
Science Immunology|2022
108 cit.
5
Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells
Nature Cancer|2022
74 cit.
6
Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulation
Cancer Cell|2023
60 cit.
7
Multiomic characterization of pancreatic cancer-associated macrophage polarization reveals deregulated metabolic programs driven by the GM-CSF–PI3K pathway
eLife|2022
53 cit.
8
Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer
Nature Cancer|2022
47 cit.
9
Visual barcodes for clonal-multiplexing of live microscopy-based assays
Nature Communications|2022
29 cit.
10
Tumor-resident microbes: the new kids on the microenvironment block
Trends in cancer|2024
24 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Markus W. Büchler
Heidelberg University
2
David A. Tuveson
Cold Spring Harbor Laboratory
3
Ralph H. Hruban
Johns Hopkins University
4
Keith D. Lillemoe
Harvard University
5
Charles J. Yeo
Thomas Jefferson University
6
John L. Cameron
Johns Hopkins University
7
Sean M. Grimmond
Center for Genomic Science
8
Michael Goggins
Johns Hopkins University
9
Andrew L. Warshaw
Harvard University
10
Michel Ducreux
Université Paris-Saclay

Papers

1
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
New England Journal of Medicine|2011
7.8k cit.
2
Genomic analyses identify molecular subtypes of pancreatic cancer
Nature|2016
3.7k cit.
3
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Science|2009
3.1k cit.
4
Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)
Surgery|2007
3k cit.
5
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
New England Journal of Medicine|2004
2.7k cit.
6
Whole genomes redefine the mutational landscape of pancreatic cancer
Nature|2015
2.7k cit.
7
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
Cancer Cell|2005
2.6k cit.
8
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Cancer Cell|2003
2.5k cit.
9
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
The Journal of Experimental Medicine|2017
2.5k cit.
10
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Nature|2011
2.2k cit.

Reagents for Pancreatic and Hepatic Oncology Research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Miltenyi BiotecEvidence 78

MHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, PE

Cited in 17 papers
#130-136-356
View Evidence →
Santa Cruz BiotechnologyEvidence 74

KRAS Antibody (B-12)

Cited in 17 papers
#sc-518124
View Evidence →
Miltenyi BiotecEvidence 78

MHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, Vio667

Cited in 17 papers
#130-135-297
View Evidence →

🌟 All-Time

Most validated

NovusEvidence 74

KRAS Antibody (OTI2C1) [DyLight 350]

Cited in 21 papers
#NBP2-71079UV
View Evidence →
NovusEvidence 74

KRAS Antibody (OTI2C1) [DyLight 405]

Cited in 21 papers
#NBP2-71079V
View Evidence →
Cell Signaling TechnologyEvidence 64

GRB7 (E3W4G) Rabbit Monoclonal Antibody

Cited in 20 papers
#76518$161,351
View Evidence →